Joint destruction biomarkers for antiIL-17A therapy of inflammatory joint disease
Details for Australian Patent Application No. 2008266745 (hide)
International Classifications
Event Publications
21 January 2010 PCT application entered the National Phase
PCT publication WO2008/156865 Priority application(s): WO2008/156865
4 October 2012 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp. Amendments
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008266746-Sirtuin modulating imidazothiazole compounds
2008266742-Use of benzyladenine to improve emergence of seeds treated with abscisic acid
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser